Furthermore, accumulating evidence shows that AChE has an additional non-cholinergic effect that could exacerbate AD pathology, and especially, that AChE has been discovered to colocalize with Aβ deposits in the brains of aged people and AD patients [74]. This evidence concerns the gene ACHE and Alzheimer disease.